Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

✍ Scribed by P. Skarlos; C. Christodoulou; K. T. Kalogeras; A. G. Eleftheraki; M. Bobos; A. Batistatou; C. Valavanis; O. Tzaida; E. Timotheadou; R. Kronenwett; R. M. Wirtz; I. Kostopoulos; D. Televantou; E. Koutselini; I. Papaspirou; C. A. Papadimitriou; D. Pectasides; H. Gogas; G. Aravantinos; N. Pavlidis; P. Arapantoni; D. V. Skarlos; G. Fountzilas

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 992 KB
• Volume: 69
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-011-1730-9